Thus, the overall downregulation of SULF1 from benign to advanced forms of PCa is irrespective of stroma-derived SULF1 and is consistent with our findings that loss of SULF1 accelerates PCa cancer growth in bone metastases. This evidence concerns the gene SULF1 and cancer.